SCHEMBL17201428

SCHEMBL17201428

COc1ccccc1OCc1ccc(-c2ccon2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.54
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RXRA P19793 1/20 0.49
ATM Q13315 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP19A1 P11511 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPT P10636 4/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HTR1A P08908 5/20 0.46
ADRA1D P25100 5/20 0.46
ADRA1A P35348 5/20 0.46
ADRA1B P35368 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201424 0.84 CYP1A2 (0.48) L3MBTL1CYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL15774623 0.84 RXRA (0.53) RXRACYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL17201419 0.83 CYP1A2 (0.43) NPC1RAB9ASMN1; SMN2POLBATM
SCHEMBL15774555 0.83 HPGD (0.49) NPC1RAB9ASMN1; SMN2POLBL3MBTL1
SCHEMBL15774562 0.83 CYP1A2 (0.44) CYP1A2CYP2D6CYP19A1CYP2C9CYP2C19
SCHEMBL15774603 0.81 CYP1A2 (0.45) NPC1RAB9ASMN1; SMN2POLBL3MBTL1
SCHEMBL15774688 0.81 RXRA (0.53) RXRACYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL17201435 0.80 XDH (0.42) NPC1RAB9ACYP1A2CYP2D6CYP19A1
SCHEMBL17201420 0.80 CYP1A2 (0.60) APPNPC1RAB9ASMN1; SMN2POLB
SCHEMBL15774540 0.79 MRGPRX4 (0.45) NPC1RAB9AL3MBTL1RXRACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296711-B2 Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1) HOFFMAN-LA ROCHE INC. (US) 2016-03-29 US disclosed
US-20150307463-A1 SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1) HOFFMANN-LA ROCHE INC. 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307463-A1 SUBSTITUTED ISOXAZOLE AMIDE COMPOUNDS AS INHIBITORS OF STEAROYL-COA DESATURASE 1 (SCD1) SCD, SCD5, CPT1A APP 2356/4885NPC1 317/4885RAB9A 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.